These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11508260)

  • 1. [Cholinesterase inhibitors in Alzheimer's disease].
    Ventura M; Sternon J
    J Pharm Belg; 2001; 56(3):62-8. PubMed ID: 11508260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anticholinesterases in Alzheimer's disease].
    Ventura M; Sternon J
    Rev Med Brux; 2001 Feb; 22(1):43-9. PubMed ID: 11252905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anticholinesterase agents in Alzheimer's disease].
    Ventura M; Sternon J
    Rev Med Brux; 2001 Sep; 22(4):A387-93. PubMed ID: 11680206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
    Beier MT
    Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatments for Alzheimer's disease: cholinesterase inhibitors.
    Doody RS
    J Clin Psychiatry; 2003; 64 Suppl 9():11-7. PubMed ID: 12934969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is there a treatment for Alzheimer's disease?].
    Joray S; Ghika J; von Gunten A; Büla C; Gold G; Assal F
    Rev Med Suisse; 2005 May; 1(18):1201-2, 1205-6, 1208. PubMed ID: 15977708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease.
    Relkin NR
    Expert Rev Neurother; 2007 Jun; 7(6):735-48. PubMed ID: 17561789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of Alzheimer's disease with acetylcholinesterase inhibitors].
    Dartigues JF; Poncet M
    Rev Neurol (Paris); 2008 Apr; 164 Spec No 2():F107. PubMed ID: 18680827
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of Alzheimer's disease utilising the best available evidence-based medicine -- utopia?].
    Stoppe G; Pirk O; Haupt M
    Gesundheitswesen; 2005 Jan; 67(1):20-6. PubMed ID: 15672302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of treatment with acetyl-cholinesterase inhibitors on psychopathological symptoms in Alzheimer's disease].
    Rösler M; Frey U
    Fortschr Neurol Psychiatr; 2002 Feb; 70(2):78-83. PubMed ID: 11823923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acetylcholinesterase inhibitors].
    Rioux S
    Rev Med Suisse Romande; 2003 Jul; 123(7):471-4. PubMed ID: 15088511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's drugs deliver fringe benefits. Cholinesterase inhibitors improve more than just memory.
    Auerbach SH
    Health News; 2003 Mar; 9(3):1-2. PubMed ID: 12703432
    [No Abstract]   [Full Text] [Related]  

  • 13. Galantamine: new preparation. The fourth cholinesterase inhibitor for Alzheimer's disease.
    Prescrire Int; 2001 Dec; 10(56):180-1. PubMed ID: 11824442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective pharmacologic management of Alzheimer's disease.
    Farlow MR; Cummings JL
    Am J Med; 2007 May; 120(5):388-97. PubMed ID: 17466645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Alzheimer drugs (galantamine).
    Raskind MA
    Neurologist; 2003 Sep; 9(5):235-40. PubMed ID: 12971834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease. Disease course over a two-year period under constant treatment conditions with rivastigmine].
    Wobrock T; Retz-Junginger P; Retz W; Supprian T; Rösler M
    Fortschr Neurol Psychiatr; 2003 Apr; 71(4):199-204. PubMed ID: 12677553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Are Alzheimer's drugs effective?].
    Hilkka S; Pirttilä T
    Duodecim; 2005; 121(4):345-6. PubMed ID: 15799249
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of nutritional status on the evolution of Alzheimer's disease and on response to acetylcholinesterase inhibitor treatment.
    Vellas B; Lauque S; Gillette-Guyonnet S; Andrieu S; Cortes F; Nourhashémi F; Cantet C; Ousset PJ; Grandjean H;
    J Nutr Health Aging; 2005; 9(2):75-80. PubMed ID: 15791349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should cholinesterase inhibitors be used to treat Alzheimer's disease?
    Finucane TE; Gilstad JR
    Nat Clin Pract Neurol; 2006 Mar; 2(3):118-9. PubMed ID: 16932534
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cholinergic deficiency syndrome as an indicator for the cholinesterase inhibitors].
    Lemstra AW; Eikelenboom P; van Gool WA
    Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2201-3. PubMed ID: 14640055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.